Last reviewed · How we verify

Vaginal conjugated estrogen cream 1.0gm

TriHealth Inc. · Phase 3 active Small molecule

Vaginal conjugated estrogen cream 1.0gm is a estrogen replacement therapy Small molecule drug developed by TriHealth Inc.. It is currently in Phase 3 development for Treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause or breast cancer treatment. Also known as: Premarin.

Estrogen replacement therapy to alleviate menopausal symptoms.

Estrogen replacement therapy to alleviate menopausal symptoms. Used for Treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause or breast cancer treatment.

At a glance

Generic nameVaginal conjugated estrogen cream 1.0gm
Also known asPremarin
SponsorTriHealth Inc.
Drug classestrogen replacement therapy
ModalitySmall molecule
Therapeutic areaWomen's Health
PhasePhase 3

Mechanism of action

Vaginal conjugated estrogen cream works by releasing estrogen directly into the vagina, which helps to alleviate symptoms of menopause such as vaginal dryness and pain during sex. This is achieved by mimicking the natural estrogen levels in the body, promoting healthy vaginal tissue and reducing inflammation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Vaginal conjugated estrogen cream 1.0gm

What is Vaginal conjugated estrogen cream 1.0gm?

Vaginal conjugated estrogen cream 1.0gm is a estrogen replacement therapy drug developed by TriHealth Inc., indicated for Treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause or breast cancer treatment.

How does Vaginal conjugated estrogen cream 1.0gm work?

Estrogen replacement therapy to alleviate menopausal symptoms.

What is Vaginal conjugated estrogen cream 1.0gm used for?

Vaginal conjugated estrogen cream 1.0gm is indicated for Treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause or breast cancer treatment.

Who makes Vaginal conjugated estrogen cream 1.0gm?

Vaginal conjugated estrogen cream 1.0gm is developed by TriHealth Inc. (see full TriHealth Inc. pipeline at /company/trihealth-inc).

Is Vaginal conjugated estrogen cream 1.0gm also known as anything else?

Vaginal conjugated estrogen cream 1.0gm is also known as Premarin.

What drug class is Vaginal conjugated estrogen cream 1.0gm in?

Vaginal conjugated estrogen cream 1.0gm belongs to the estrogen replacement therapy class. See all estrogen replacement therapy drugs at /class/estrogen-replacement-therapy.

What development phase is Vaginal conjugated estrogen cream 1.0gm in?

Vaginal conjugated estrogen cream 1.0gm is in Phase 3.

What are the side effects of Vaginal conjugated estrogen cream 1.0gm?

Common side effects of Vaginal conjugated estrogen cream 1.0gm include Vaginal bleeding, Headache, Breast tenderness.

Related